Frank I Scott, MD MSCE (@frankiscottmd) 's Twitter Profile
Frank I Scott, MD MSCE

@frankiscottmd

account not active due to fascist ownership of X. find me at @frankiscottmd.bsky.social

ID: 991686963844603904

calendar_today02-05-2018 14:32:51

620 Tweet

1,1K Followers

905 Following

Frank I Scott, MD MSCE (@frankiscottmd) 's Twitter Profile Photo

Taylor Karl presenting our modeling data suggesting that fecal calprotectin monitoring reduces costs and improves quality of life in comparison to colonoscopic assessment in low risk post operative CD, supporting recently published guideline revisions Ben Click CU Division of Gastroenterology and Hepatology

Taylor Karl presenting our modeling data suggesting that fecal calprotectin monitoring reduces costs and improves quality of life in comparison to colonoscopic assessment in low risk post operative CD, supporting recently published guideline revisions <a href="/BenClickMD/">Ben Click</a> <a href="/CUGastroHep/">CU Division of Gastroenterology and Hepatology</a>
American Gastroenterological Association (AGA) (@amergastroassn) 's Twitter Profile Photo

🔔 AGA's living guideline on the pharmacological management of mod/severe UC is now open for public comment! Here’s your chance to get an advanced look at our next guideline and share your feedback 💬 ow.ly/JH4A50SwSw7

Nathan Grellier (@nathangrellier5) 's Twitter Profile Photo

Comparative Efficacy of Advanced Therapies for Management of Moderate-to-Severe Ulcerative Colitis: 2024 American Gastroenterological Association Evidence Synthesis - Gastroenterology gastrojournal.org/article/S0016-…

AJG - The American Journal of Gastroenterology (@amjgastro) 's Twitter Profile Photo

In the 📕#RedJournal: Insurer-Mandated Medication Utilization Barriers are Associated With Decreased Insurance Satisfaction and Adverse Clinical Outcomes: An IBD Partners Survey Constant, et al. 👉 bit.ly/4hiHSNN Brad D Constant MD Millie Long Frank I Scott, MD MSCE Peter Higgins

In the 📕#RedJournal:

Insurer-Mandated Medication Utilization Barriers are Associated With Decreased Insurance Satisfaction and Adverse Clinical Outcomes: An IBD Partners Survey
Constant, et al. 

👉 bit.ly/4hiHSNN
<a href="/BradDConstantMD/">Brad D Constant MD</a> <a href="/MLongMD/">Millie Long</a> <a href="/FrankIScottMD/">Frank I Scott, MD MSCE</a> <a href="/ibddoctor/">Peter Higgins</a>
Lilia Cervantes (@cervantes_lily1) 's Twitter Profile Photo

Mentorship Academy—the one and only Vineet Chopra on “Mentorship Malpractice” -Two categories: (1) active (dysfunctional behavior/easy to spot) & (2) passive (insidious). jamanetwork.com/journals/jama/…

Mentorship Academy—the one and only <a href="/vineet_chopra/">Vineet Chopra</a> on “Mentorship Malpractice”
-Two categories: (1) active (dysfunctional behavior/easy to spot) &amp; (2) passive (insidious).

jamanetwork.com/journals/jama/…
American Gastroenterological Association (AGA) (@amergastroassn) 's Twitter Profile Photo

🌟 Our first-ever living guideline for managing moderate-to-severe #UlcerativeColitis led by Berkeley Limketkai, @manasiagrawalmd, @Jhaydek, @ashwinmdibd, Frank I Scott, MD MSCE, Edward Loftus prioritizes early use of advanced therapies over a step-up approach. ow.ly/t2Ru50UahEi

🌟 Our first-ever living guideline for managing moderate-to-severe #UlcerativeColitis led by <a href="/berkeleydoc/">Berkeley Limketkai</a>, @manasiagrawalmd, @Jhaydek, @ashwinmdibd, <a href="/FrankIScottMD/">Frank I Scott, MD MSCE</a>, <a href="/EdwardLoftus2/">Edward Loftus</a> prioritizes early use of advanced therapies over a step-up approach.  

ow.ly/t2Ru50UahEi
American Gastroenterological Association (AGA) (@amergastroassn) 's Twitter Profile Photo

🆕 AGA guideline alert! For moderate-to-severe #Ulcerativecolitis, Berkeley Limketkai, @manasiagrawalmd, John Haydek, MD MS, Ashwin,M.D, Frank I Scott, MD MSCE, Edward Loftus, rank 12 therapies by efficacy. This living guideline will refresh every six months with new data. ow.ly/pKM150Uan6u

CU Division of Gastroenterology and Hepatology (@cugastrohep) 's Twitter Profile Photo

We are excited to welcome this 🌟lineup to CU Division of Gastroenterology and Hepatology and can’t wait to work w/ these future leaders in #Gastroenterology and #Hepatology! 🎉Congrats Drs. Mohanad Awadalla, Julie Giannini, Rachna Talluri, Alejandra Vargas, Kia Vosoughi! #FellowshipMatch #WelcometoGI Mohanad Awadalla

We are excited to welcome this 🌟lineup to <a href="/CUGastroHep/">CU Division of Gastroenterology and Hepatology</a> and can’t wait to work w/ these future leaders in #Gastroenterology and #Hepatology! 🎉Congrats Drs. Mohanad Awadalla, Julie Giannini, Rachna Talluri, Alejandra Vargas, Kia Vosoughi! #FellowshipMatch #WelcometoGI <a href="/AwadallaMD/">Mohanad Awadalla</a>
Jami Kinnucan, MD, FACG, AGAF, FCCF (@ibdgijami) 's Twitter Profile Photo

Some important work highlighting that there is a gap is what is available for #EHR optimization in the care of #IBD patients and what is being used by colleagues Check out poster #55 at @IBDConference #AIBD2024 Collaboration with @VUMCibd Mayo Clinic Florida Gastroenterology & Hepatology Sara Horst MD, MPH, FACG

Some important work highlighting that there is a gap is what is available for #EHR optimization in the care of #IBD patients and what is being used by colleagues 

Check out poster #55 at <a href="/IBDConference/">@IBDConference</a> #AIBD2024 

Collaboration with @VUMCibd <a href="/MayoClinicFLGIH/">Mayo Clinic Florida Gastroenterology & Hepatology</a> <a href="/HorstIBDDoc/">Sara Horst MD, MPH, FACG</a>
F. Perry Wilson, MD MSCE (@fperrywilson) 's Twitter Profile Photo

NIH has announced a cut in the "indirect rate" to 15% across the board, in a move that appears to be retroactive to even existing grants. This is a bloodbath for research institutions throughout the country. Brief explainer for those not in this world: buff.ly/3EtML7D